2006Journal of Yangtze UniversityRequires access

Observations on Theraputic Effect of Oxymatrine on Liver Fibrosis Resulted from Chronic Hepatitis B

Zhao We

Open publisher page 0 citations

Abstract

Objective: To observe the efficacy of Oxymatrine in treating of patients with fibrosis of hepatitis B.Methods: 43 patients with chronic hepatitis B were randomly divided into the treated group(22 cases) and the control group(21 cases),Patients in both groups received conventional drugs for 24 weeks,however,Patients in treated group also received Oxymatrine 600mg per oral daily for 24 weeks.HBeAg in ELISA and HBV-DNA with PCR were measured,Serum HA,LN,CIV and PCIII were measured in the above patients by radiommunoassay at 0,24 weeks treatment.Results: HBeAg of 8 in 22 cases(36.4%) of the treated group converted to negative,and HBV-DNA of 12 in 22 cases(54.5%) of the treated group converted to nagative.The serum levels of HA,LN,CIV and PCIII were decreased in the treated group,but there were no change during the period in the control group.There was significant difference between the two groups.Conclusion: Oxymatrine combined with conventional drugs is effective in treatment of fibrosis of chronic hepatitis B.

About this research paper

What this paper is about

Objective: To observe the efficacy of Oxymatrine in treating of patients with fibrosis of hepatitis B.Methods: 43 patients with chronic hepatitis B were randomly divided into the treated group(22 cases) and the control group(21 cases),Patients in both groups received conventional drugs for 24 weeks,however,Patients in treated group also received Oxymatrine 600mg per oral daily for 24 weeks.HBeAg in ELISA and HBV-DNA with PCR were measured,Serum HA,LN,CIV and PCIII were measured in the above patients by radiommunoassay at 0,24 weeks treatment.Results: HBeAg of 8 in 22 cases(36.4%) of the treated group converted to negative,and HBV-DNA of 12 in 22 cases(54.5%) of the treated group converted to nagative.The serum levels of HA,LN,CIV and PCIII were decreased in the treated group,but there were no change during the period in the control group.There was significant difference between the two groups.Conclusion: Oxymatrine combined with conventional drugs is effective in treatment of fibrosis of chronic hepatitis B.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To observe the efficacy of Oxymatrine in treating of patients with fibrosis of hepatitis B.Methods: 43 patients with chronic hepatitis B were randomly divided into the treated group(22 cases) and the control group(21 cases),Patients in both groups received conventional drugs for 24 weeks,however,Patients in treated group also received Oxymatrine 600mg per oral daily for 24 weeks.HBeAg in ELISA and HBV-DNA with PCR were measured,Serum HA,LN,CIV and PCIII were measured in the above patients by radiommunoassay at 0,24 weeks treatment.Results: HBeAg of 8 in 22 cases(36.4%) of the treated group converted to negative,and HBV-DNA of 12 in 22 cases(54.5%) of the treated group converted to nagative.The serum levels of HA,LN,CIV and PCIII were decreased in the treated group,but there were no change during the period in the control group.There was significant difference between the two groups.Conclusion: Oxymatrine combined with conventional drugs is effective in treatment of fibrosis of chronic hepatitis B.

Key concepts: Oxymatrine, HBeAg, Medicine, Chronic hepatitis, Gastroenterology, Internal medicine, Liver fibrosis, Fibrosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Observations on Theraputic Effect of Oxymatrine on Liver Fibrosis Resulted from Chronic Hepatitis B — Research Paper | ScholarLens